Epstein Secrets

nvestmere Orme* ad risk profile at speck to each account and may ary Minoan Please adele the Firmpromptly in man; of any eisnilkart change in your Merck Owner or memo" objectives. Foe each CONFIDENTIAL account red, you choose one of the following element plucker • Praha. Current/mom.. hob.* es sre

Account number: Your current asset allocation E Eye on the markets Index Percentage change October 2015 Year to date S&P 500 8.44% 2.70% Russell 3000 7.90% 2.02% MSC I - Europe, Australia & Far East 7.82% 2.53% BarclaysCapital U.S. Aggregate Bond Index 0.02% 1.14% Your K modal Advisor 7'

. Account number: Your current asset allocation Eye on the markets Index Percentage change December 2015 Year to date S&P 500 -1.58% 1.38% Russell 3000 -2.05% 0.48% MSC - Europe, Australia & Far East -1.33% -0.39% Barclays Capital U.S. Aggregate Bond Index -0.32% 0.55% Your K asocial Advisor.

to sea Figh returns owe tint • lin. stment (Wake Comaration:t Hinted, a PatiOn of the portfolio for at account may ladle canals strategic, limited Merck andante Starr Thoweholteut We may corsoklase al related account statements with the sane adrass it the same envelope, e.g. because they have own

Account number: Your current asset allocation A Eye on the markets Index Percentage change October 2015 year to date S&P 500 8.44% 2.70% Russell 3000 7.90% 2.02% MSC I - Europe, Australia & Far East 7.82% 2.53% Barclays Capital U.S. Aggregate Bond Index 0.02% 1.14% Your Financial Advisor

Account number. Your current asset allocation A Eye on the markets Index Percentage change December 2015 Year to date SW 500 -1.58% 1.38% Russell 3000 -2.05% 0.48% MSC - Europe, Australia & Far East -1.33% -0 39% Barclays Capital U.S. Aggregate Bond Index -0.32% 0.55% Your financial Advisor.

) and Tioga. He was previously on the boards of Intarcia Therapuetics (now currently a Board observer), Sirna Therapeutics (NASDAQ: RNAI, acquired by Merck in 2006 for $1.1 billion), where he served as Chairman; Oriel Therapeutics (acquired by Novartis in 2010), where he served as Executive Chairman, and

ppendices” including endnote C in Appendix 4 regarding information provided by Cambridge Associates. 3 S&P500, S&P Healthcare, NASDAQ Composite, and Russell 3000. See endnote F in Appendix 4. * Please refer to Section III: “Summary of Historical Investment Performance” and Section XIII: “Appendices; Appendix